Viewing Study NCT03921866


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-13 @ 8:57 AM
Study NCT ID: NCT03921866
Status: COMPLETED
Last Update Posted: 2023-03-17
First Post: 2019-04-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: UK Ibrance Patient Program (IPP) Study
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-03-01
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-04
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-04
Completion Date Type: ACTUAL
First Submit Date: 2019-04-17
First Submit QC Date: None
Study First Post Date: 2019-04-19
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-03-03
Results First Submit QC Date: None
Results First Post Date: 2023-03-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-03
Last Update Post Date: 2023-03-17
Last Update Post Date Type: ACTUAL